{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:02:12Z","timestamp":1768536132987,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["18170352"],"award-info":[{"award-number":["18170352"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.apsb.2025.04.014","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T15:14:22Z","timestamp":1745075662000},"page":"3163-3180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Design, synthesis and biological evaluation of a novel class of indazole-containing compounds with potent anti-influenza activities targeting the PA-PB1 interface"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4873-8712","authenticated-orcid":false,"given":"Yun-Sang","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0356-2938","authenticated-orcid":false,"given":"Nuermila","family":"Yiliyaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Er-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang-Chui","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.04.014_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/502973","article-title":"Clinical features of influenza C virus infection in children","volume":"193","author":"Matsuzaki","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2025.04.014_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01051-20","article-title":"Molecular characterization of influenza C viruses from outbreaks in Hong Kong SAR, China","volume":"94","author":"Daniels","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2025.04.014_bib4","series-title":"Virus protein and nucleoprotein complexes","first-page":"95","article-title":"Structure and function of influenza virus ribonucleoprotein","volume":"vol. 88","author":"Lo","year":"2018"},{"key":"10.1016\/j.apsb.2025.04.014_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104780","article-title":"Put a cork in it: plugging the M2 viral ion channel to sink influenza","volume":"178","author":"Jalily","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2025.04.014_bib6","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/v15122446","article-title":"Genomic analysis of influenza A and B viruses carrying baloxavir resistance-associated substitutions serially passaged in human epithelial cells","volume":"15","author":"Hickerson","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2025.04.014_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2025.04.014_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","article-title":"Influenza virus susceptibility and resistance to oseltamivir","author":"Aoki","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.apsb.2025.04.014_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcv.2011.05.019","article-title":"Emerging oseltamivir resistance in seasonal and pandemic influenza A\/H1N1","volume":"52","author":"Renaud","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.apsb.2025.04.014_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10822-019-00251-7","article-title":"Source of oseltamivir resistance due to single E119D and double E119D\/H274Y mutations in pdm09H1N1 influenza neuraminidase","volume":"34","author":"Hanpaibool","year":"2020","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.apsb.2025.04.014_bib11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00705-022-05456-0","article-title":"A novel E198K substitution in the PA gene of influenza A virus with reduced susceptibility to baloxavir acid","volume":"167","author":"Takizawa","year":"2022","journal-title":"Arch Virol"},{"key":"10.1016\/j.apsb.2025.04.014_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nature07120","article-title":"Crystal structure of the polymerase PAC\u2013PB1N complex from an avian influenza H5N1 virus","volume":"454","author":"He","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.014_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/febs.12107","article-title":"A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly","volume":"280","author":"Li","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2025.04.014_bib14","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1073\/pnas.1119817109","article-title":"Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase","volume":"109","author":"Muratore","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.014_bib15","first-page":"1","article-title":"Exploring ugi-azide four-component reaction products for broad-spectrum influenza antivirals with a high genetic barrier to drug resistance","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.04.014_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/acschembio.9b00552","article-title":"Discovery of influenza polymerase PA-PB1 interaction inhibitors using an in vitro split-luciferase complementation-based assay","volume":"15","author":"Zhang","year":"2020","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.apsb.2025.04.014_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/acs.jmedchem.1c01527","article-title":"Lead optimization of influenza virus RNA polymerase inhibitors targeting PA-PB1 interaction","volume":"65","author":"Mizuta","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.014_bib18","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acsinfecdis.0c00552","article-title":"Inhibition of influenza virus polymerase by interfering with its protein-protein interactions","volume":"7","author":"Massari","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2025.04.014_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cmdc.201300378","article-title":"The fight against the influenza A virus H1N1: synthesis, molecular modeling, and biological evaluation of benzofurazan derivatives as viral RNA polymerase inhibitors","volume":"9","author":"Pagano","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.apsb.2025.04.014_bib20","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1016\/j.bmcl.2013.08.048","article-title":"Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus","volume":"23","author":"Kessler","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2025.04.014_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1021\/mp900131p","article-title":"Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation","volume":"7","author":"Liu","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.04.014_bib22","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) Viruses","volume":"54","author":"Sleeman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2025.04.014_bib23","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3201\/eid2510.190607","article-title":"Susceptibility of influenza A, B, C, and D viruses to baloxavir","volume":"25","author":"Mishin","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.apsb.2025.04.014_bib24","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1128\/JVI.78.17.9144-9153.2004","article-title":"The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex","volume":"78","author":"Fodor","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2025.04.014_bib25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JVI.01533-09","article-title":"Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy","volume":"84","author":"Huet","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2025.04.014_bib26","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/molecules23112783","article-title":"Recent advances in indazole-containing derivatives: synthesis and biological perspectives","volume":"23","author":"Zhang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2025.04.014_bib27","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1016\/j.bmc.2014.12.011","article-title":"Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A\/2C partial agonists","volume":"23","author":"Hansen","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2025.04.014_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s41981-021-00166-1","article-title":"Improving the reaction efficiency of condensation amidation of piperazine with benzoic acid based on kinetics study in microreactors","volume":"11","author":"Xu","year":"2021","journal-title":"J Flow Chem"},{"key":"10.1016\/j.apsb.2025.04.014_bib29","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1021\/jo901569v","article-title":"Functional group tolerance in organocatalytic regioselective acylation of carbohydrates","volume":"74","author":"Ueda","year":"2009","journal-title":"J Org Chem"},{"key":"10.1016\/j.apsb.2025.04.014_bib30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10973-014-4259-4","article-title":"On the existence of \u201cthiourea urea magnesium chloride\u201d and \u201curea thiourea sodium chloride.\u201d","volume":"119","author":"Srinivasan","year":"2015","journal-title":"J Therm Anal Calorim"},{"key":"10.1016\/j.apsb.2025.04.014_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115775","article-title":"Anti-influenza virus activities and mechanism of antrafenine analogs","volume":"260","author":"Tang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.014_bib32","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.3390\/molecules27175724","article-title":"Urolithin M5 from the leaves of Canarium album (Lour.) DC. inhibits influenza virus by targeting neuraminidase","volume":"27","author":"Xiao","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2025.04.014_bib33","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41598-018-20772-9","article-title":"Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening","volume":"8","author":"Lo","year":"2018","journal-title":"Sci Rep"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:20:26Z","timestamp":1750807226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525002679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2211383525002679"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.014","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of a novel class of indazole-containing compounds with potent anti-influenza activities targeting the PA-PB1 interface","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}